Glutamic Acid
CAS 56-86-0
Glutamic Acid (CAS 56-86-0) is a Phase 3 pharmaceutical compound with 27 bioactivity targets and 2 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | EC50 | 19779.175698324023 nM | 156 | - |
| - | Ki | 5053.974411764706 nM | 92 | - |
| - | IC50 | 10193.532063492064 nM | 54 | - |
| - | AC50 | 30158.23741935484 nM | 32 | - |
| - | Potency | 13790.855555555556 nM | 8 | - |
| Adenosine receptor A3 GPCR |
IC50 | 6.21 | - | Homo sapiens |
| Glutathione reductase, mitochondrial Enzyme |
Ki | 4.37 | - | Homo sapiens |
| Glutamate receptor 1 Ion channel |
Ki | 5.87 | - | Homo sapiens |
| Glutamate receptor ionotropic, kainate 1 Ion channel |
Ki | 6.15 | - | Homo sapiens |
| Glutamate receptor 2 Ion channel |
Ki | 6.03 | - | Homo sapiens |
| Metabotropic glutamate receptor 1 GPCR |
Ki | 6.6 | - | Homo sapiens |
| Glutamate dehydrogenase 1, mitochondrial Enzyme |
- | - | - | Homo sapiens |
| Glutamate dehydrogenase 2, mitochondrial Enzyme |
- | - | - | Homo sapiens |
| Glutamate receptor ionotropic, kainate 5 Ion channel |
Ki | 6.15 | - | Homo sapiens |
| Metabotropic glutamate receptor 5 GPCR |
Ki | 6.41 | - | Homo sapiens |
| Metabotropic glutamate receptor 4 GPCR |
Ki | 5.85 | - | Homo sapiens |
| Glutamate receptor 4 Ion channel |
Ki | 6.06 | - | Homo sapiens |
| Glutamate receptor ionotropic, kainate 2 Ion channel |
Ki | 5.96 | - | Homo sapiens |
| Glutamate receptor ionotropic, kainate 3 Ion channel |
Ki | 6.1 | - | Homo sapiens |
| Metabotropic glutamate receptor 7 GPCR |
EC50 | 5.93 | - | Homo sapiens |
| Metabotropic glutamate receptor 6 GPCR |
EC50 | 5.31 | - | Homo sapiens |
| Metabotropic glutamate receptor 2 GPCR |
EC50 | 6.54 | - | Homo sapiens |
| Excitatory amino acid transporter 1 Transporter |
Ki | 4.46 | - | Homo sapiens |
| Excitatory amino acid transporter 2 Transporter |
Ki | 4.21 | - | Homo sapiens |
| Excitatory amino acid transporter 3 Transporter |
Ki | 7.29 | - | Homo sapiens |
| Glutamate receptor 2 Ion channel |
Ki | 6.55 | - | Rattus norvegicus |
| Glutamate receptor 3 Ion channel |
Ki | 6.595 | - | Homo sapiens |
| Glutamate receptor ionotropic, kainate 4 Ion channel |
Ki | 7.738 | - | Homo sapiens |
| Metabotropic glutamate receptor 3 GPCR |
Ki | 7.4 | - | Homo sapiens |
| Metabotropic glutamate receptor 8 GPCR |
IC50 | 5.7 | - | Homo sapiens |
| Glutamate receptor ionotropic, NMDA 1 Ion channel |
EC50 | 5.54 | - | Rattus norvegicus |
| Glutamate receptor ionotropic, kainate 2 Ion channel |
Ki | 5.48 | - | Rattus norvegicus |
| Glutamate receptor ionotropic, kainate 1 Ion channel |
Ki | 6.85 | - | Rattus norvegicus |
| Metabotropic glutamate receptor 4 GPCR |
EC50 | 4.92 | - | Rattus norvegicus |
| Metabotropic glutamate receptor 6 GPCR |
EC50 | 4.8 | - | Rattus norvegicus |
| Glutamate receptor 1 Ion channel |
EC50 | 4.46 | - | Rattus norvegicus |
| Glutamate receptor 3 Ion channel |
EC50 | 4 | - | Rattus norvegicus |
| Glutamate receptor 4 Ion channel |
EC50 | 4.77 | - | Rattus norvegicus |
| Glutamate receptor ionotropic, kainate 3 Ion channel |
Ki | 6.31 | - | Rattus norvegicus |
| Glutamate racemase Enzyme |
Ki | 4.55 | - | Lactobacillus fermentum |
| Metabotropic glutamate receptor 8 GPCR |
Ki | 5.47 | - | Rattus norvegicus |
| Metabotropic glutamate receptor 8 GPCR |
EC50 | 7.66 | - | Mus musculus |
| Metabotropic glutamate receptor 5 GPCR |
EC50 | 5.36 | - | Rattus norvegicus |
| Metabotropic glutamate receptor 1 GPCR |
EC50 | 5 | - | Rattus norvegicus |
| Metabotropic glutamate receptor 2 GPCR |
EC50 | 5.4 | - | Rattus norvegicus |
| Metabotropic glutamate receptor 3 GPCR |
EC50 | 5.52 | - | Rattus norvegicus |
| Glutamate racemase Enzyme |
Ki | 5.24 | - | Helicobacter pylori (strain ATCC 700392 / 26695) |
| Excitatory amino acid transporter 4 Transporter |
IC50 | 4.89 | - | Rattus norvegicus |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Toxic epidermal necrolysis | 21 | 76.155 | 10044223 |
| Foetal growth restriction | 15 | 66.301 | 10070531 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| mGlu 1 receptor GRM1 |
Agonist | 4.800000190734863 pEC50 | 10443583 |
| mGlu 1 receptor Grm1 |
Full agonist | 6.4 pKi | 12695537|11080213 |
| mGlu 2 receptor GRM2 |
Agonist | 4.699999809265137 pEC50 | 10443583 |
| mGlu 2 receptor Grm2 |
Full agonist | 5.4 pKi | 8022410|10652549 |
| mGlu 2 receptor GRM2 |
Full agonist | 4.9 pKi | 10530814 |
| mGlu 3 receptor GRM3 |
Agonist | 5.300000190734863 pEC50 | 10443583 |
| mGlu 3 receptor GRM3 |
Full agonist | 7.4 pKi | 10530814 |
| mGlu 3 receptor Grm3 |
Full agonist | 6.4 pKi | 10884552 |
| mGlu 4 receptor GRM4 |
Agonist | 4.699999809265137 pEC50 | 10443583 |
| mGlu 4 receptor Grm4 |
Full agonist | 4.9 pKi | 9144638|10187777|1361913|9357538 |
| mGlu 5 receptor GRM5 |
Agonist | 5.0 pEC50 | 10443583 |
| mGlu 5 receptor Grm5 |
Full agonist | 6.1 pIC50 | 11080213 |
| mGlu 6 receptor GRM6 |
Agonist | 4.800000190734863 pEC50 | 10443583 |
| mGlu 6 receptor Grm6 |
Full agonist | 4.4 pEC50 | 9833633 |
| mGlu 6 receptor GRM6 |
Full agonist | 5.2 pEC50 | 9144651 |
| mGlu 7 receptor GRM7 |
Agonist | 3.0 pEC50 | 10443583 |
| mGlu 7 receptor GRM7 |
Full agonist | 3.1 pKi | 11138847 |
| mGlu 8 receptor GRM8 |
Agonist | 4.900000095367432 pEC50 | 10443583 |
| mGlu 8 receptor GRM8 |
Full agonist | 5.0 pIC50 | 9473604|10216218 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| glutamic acid | 25916 | SU | MTHSPL |
| Glutamic Acid | 25916 | SU | MTHSPL |
| GLUTAMIC ACID | 25916 | SU | MTHSPL |
| glutamic acid | 25916 | PIN | RXNORM |
| glutamate | 70602 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Glutamic Acid used for in pharmaceutical contexts?
Glutamic Acid (CAS 56-86-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Glutamic Acid?
Glutamic Acid has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Toxic epidermal necrolysis, Foetal growth restriction. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Glutamic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for L-Glutamic Acid with EU status "permitted".
What clinical phase is Glutamic Acid in?
Glutamic Acid is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Glutamic Acid?
Glutamic Acid has 48 bioactivity rows in this page query. Rendered target entries include Adenosine receptor A3, Glutathione reductase, mitochondrial, Glutamate receptor 1, Glutamate receptor ionotropic, kainate 1, Glutamate receptor 2.